Balance Sheet InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 09:30:00 2025-01-22 am EST			5-day change	1st Jan Change
0.1800 ^CAD	0.00%		0.00%	-14.29%

Dec. 31	Innocan Pharma Closes Private Placement for $635,444	MT
Dec. 30	InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding	CI

6f6f45893e21.i05sAdQxtXG1PtqM2Ja2y14VsSkba_Qmc_nEn7QU1Bk.5TYpLLAEzxr4C5fjmaPB_TVW1GooHLhTBryh78NemS3pCCZwkGaDRdBW4g

Published financial data: INNOCAN PHARMA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	-	8K	196K	2.56M	13.66M
Total Revenues	-	8K	196K	2.56M	13.66M
Cost of Goods Sold, Total	-	5K	75K	452K	1.68M
Gross Profit	-	3K	121K	2.11M	11.98M
Selling General & Admin Expenses, Total	2.63M	2.98M	6.2M	6.85M	13.98M
R&D Expenses	368K	1.74M	1.4M	1.53M	1.8M
Other Operating Expenses, Total	3M	4.73M	7.6M	8.37M	15.78M
Operating Income	-3M	-4.72M	-7.48M	-6.27M	-3.8M
Interest Expense, Total	-40K	-	-13K	-2K	-
Interest And Investment Income	-	21K	-	-	-
Net Interest Expenses	-40K	21K	-13K	-2K	-
Currency Exchange Gains (Loss)	-	-	-290K	-415K	4K
Other Non Operating Income (Expenses)	-294K	-5.25M	-2.31M	2.8M	-235K
EBT, Excl. Unusual Items	-3.34M	-9.95M	-10.09M	-3.89M	-4.03M
EBT, Incl. Unusual Items	-3.34M	-9.95M	-10.09M	-3.89M	-4.03M
Income Tax Expense	-	-	-	1K	214K
Earnings From Continuing Operations	-3.34M	-9.95M	-10.09M	-3.89M	-4.25M
Net Income to Company	-3.34M	-9.95M	-10.09M	-3.89M	-4.25M
Minority Interest	-	-	44K	125K	-452K
Net Income - (IS)	-3.34M	-9.95M	-10.05M	-3.76M	-4.7M
Net Income to Common Incl Extra Items	-3.34M	-9.95M	-10.05M	-3.76M	-4.7M
Net Income to Common Excl. Extra Items	-3.34M	-9.95M	-10.05M	-3.76M	-4.7M
Per Share Items
Net EPS - Basic	-0.03	-0.06	-0.04	-0.02	-0.02
Basic EPS - Continuing Operations	-0.03	-0.06	-0.04	-0.02	-0.02
Basic Weighted Average Shares Outstanding	121M	162M	225M	249M	257M
Net EPS - Diluted	-0.03	-0.06	-0.04	-0.02	-0.02
Diluted EPS - Continuing Operations	-0.03	-0.06	-0.04	-0.02	-0.02
Diluted Weighted Average Shares Outstanding	121M	162M	225M	249M	257M
Normalized Basic EPS	-0.02	-0.04	-0.03	-0.01	-0.01
Normalized Diluted EPS	-0.02	-0.04	-0.03	-0.01	-0.01
Supplemental Items
EBITDA	-3M	-4.68M	-7.44M	-6.23M	-3.77M
EBITA	-3M	-4.72M	-7.48M	-6.27M	-3.8M
EBIT	-3M	-4.72M	-7.48M	-6.27M	-3.8M
Effective Tax Rate - (Ratio)	-	-	-	-0.03	-5.3
Normalized Net Income	-2.08M	-6.22M	-6.26M	-2.3M	-2.97M
Interest on Long-Term Debt	334K	-	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	695K	914K	2.5M	3.49M	10.91M
General and Administrative Expenses	1.94M	2.07M	3.71M	3.36M	3.08M
Research And Development Expense From Footnotes	368K	1.74M	1.4M	1.53M	1.8M
Stock-Based Comp., R&D Exp. (Total)	57K	64K	109K	120K	102K
Stock-Based Comp., S&M Exp. (Total)	121K	121K	490K	223K	96K
Stock-Based Comp., G&A Exp. (Total)	248K	343K	1.56M	624K	656K
Stock-Based Comp., Other (Total)	-	-	-1K	-	-
Total Stock-Based Compensation	426K	528K	2.16M	967K	854K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.97M	2.34M	11.05M	4.95M	3.88M
Total Cash And Short Term Investments	1.97M	2.34M	11.05M	4.95M	3.88M
Accounts Receivable, Total	-	2K	-	62K	249K
Other Receivables	57K	1.13M	169K	181K	445K
Total Receivables	57K	1.13M	169K	243K	694K
Inventory	-	430K	510K	1.13M	1.75M
Prepaid Expenses	426K	309K	715K	453K	340K
Other Current Assets, Total	31K	72K	79K	104K	138K
Total Current Assets	2.49M	4.28M	12.52M	6.88M	6.8M
Net Property Plant And Equipment	95K	56K	54K	98K	136K
Total Assets	2.58M	4.33M	12.58M	6.98M	6.94M
Liabilities
Accounts Payable, Total	27K	527K	53K	95K	112K
Accrued Expenses, Total	409K	384K	432K	318K	463K
Current Portion of Leases	34K	37K	1K	14K	22K
Other Current Liabilities	661K	6.99M	3.08M	304K	1.95M
Total Current Liabilities	1.13M	7.94M	3.56M	731K	2.54M
Long-Term Leases	38K	1K	-	20K	11K
Total Liabilities	1.17M	7.94M	3.56M	751K	2.55M
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	6.02M	10.96M	33.66M	34.77M	37.18M
Retained Earnings	-4.61M	-14.56M	-24.61M	-28.37M	-33.07M
Total Common Equity	1.41M	-3.61M	9.06M	6.39M	4.1M
Minority Interest	-	-	-44K	-169K	283K
Total Equity	1.41M	-3.61M	9.01M	6.22M	4.39M
Total Liabilities And Equity	2.58M	4.33M	12.58M	6.98M	6.94M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	144M	215M	248M	252M	281M
ECS Total Common Shares Outstanding	144M	188M	248M	250M	268M
Book Value / Share	0.01	-0.02	0.04	0.03	0.02
Tangible Book Value	1.41M	-3.61M	9.06M	6.39M	4.1M
Tangible Book Value Per Share	0.01	-0.02	0.04	0.03	0.02
Total Debt	72K	38K	1K	34K	33K
Net Debt	-1.9M	-2.3M	-11.05M	-4.91M	-3.85M
Minority Interest, Total (Incl. Fin. Div)	-	-	-44K	-169K	283K
Account Code - Inventory Valuation	3	-	5	5	5
Inventories - Raw Materials, Total	-	203K	188K	224K	214K
Inventories - Finished Goods, Total	-	227K	322K	907K	1.53M
Full Time Employees	-	-	-	-	-
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-3.34M	-9.95M	-10.05M	-3.76M	-4.7M
Depreciation & Amortization - CF	23K	40K	43K	35K	33K
Depreciation & Amortization, Total	23K	40K	43K	35K	33K
Stock-Based Compensation (CF)	426K	527K	2.16M	967K	854K
Other Operating Activities, Total	298K	5.22M	2.18M	-2.77M	702K
Change In Accounts Receivable	-63K	-2K	2K	-15K	-2K
Change In Inventories	-	-430K	-79K	-621K	-616K
Change In Accounts Payable	27K	500K	-474K	42K	17K
Change in Other Net Operating Assets	-91K	406K	-418K	63K	-192K
Cash from Operations	-2.72M	-3.69M	-6.63M	-6.07M	-3.9M
Capital Expenditure	-9K	-	-41K	-26K	-46K
Other Investing Activities, Total	-	-	-7K	-5K	-38K
Cash from Investing	-9K	-	-48K	-31K	-84K
Long-Term Debt Repaid, Total	-38K	-39K	-38K	-11K	-22K
Total Debt Repaid	-38K	-39K	-38K	-11K	-22K
Issuance of Common Stock	4.49M	4.06M	11.92M	136K	1.56M
Other Financing Activities, Total	-	-	3.43M	-	1.38M
Cash from Financing	4.45M	4.02M	15.3M	125K	2.92M
Foreign Exchange Rate Adjustments	29K	28K	84K	-128K	9K
Net Change in Cash	1.76M	365K	8.71M	-6.1M	-1.06M
Supplemental Items
Levered Free Cash Flow	-968K	2.99M	-7.41M	-6.25M	-720K
Unlevered Free Cash Flow	-943K	2.99M	-7.4M	-6.24M	-720K
Change In Net Working Capital	-493K	-5.38M	4.89M	3.3M	-816K
Net Debt Issued / Repaid	-38K	-39K	-38K	-11K	-22K

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-115.71	-85.4	-55.3	-40.06	-34.16
Return on Total Capital	-232.71	283.41	-171.78	-51.29	-44.52
Return On Equity %	-433.12	907.29	-373.46	-51.05	-80.07
Return on Common Equity	-433.12	907.29	-368.83	-48.73	-89.55
Margin Analysis
Gross Profit Margin %	-	37.5	61.73	82.34	87.71
SG&A Margin	-	37.3K	3.16K	267.57	102.4
EBITDA Margin %	-	-58.56K	-3.79K	-243.49	-27.6
EBITA Margin %	-	-59.06K	-3.82K	-244.86	-27.85
EBIT Margin %	-	-59.06K	-3.82K	-244.86	-27.85
Income From Continuing Operations Margin %	-	-124K	-5.15K	-151.97	-31.1
Net Income Margin %	-	-124K	-5.13K	-147.09	-34.41
Net Avail. For Common Margin %	-	-124K	-5.13K	-147.09	-34.41
Normalized Net Income Margin	-	-77.76K	-3.2K	-90.07	-21.77
Levered Free Cash Flow Margin	-	37.44K	-3.78K	-244.06	-5.27
Unlevered Free Cash Flow Margin	-	37.44K	-3.78K	-244.01	-5.27
Asset Turnover
Asset Turnover	-	0	0.02	0.26	1.96
Fixed Assets Turnover	-	0.11	3.56	33.67	116.73
Receivables Turnover (Average Receivables)	-	-	-	-	87.83
Inventory Turnover (Average Inventory)	-	-	0.16	0.55	1.17
Short Term Liquidity
Current Ratio	2.2	0.54	3.51	9.41	2.68
Quick Ratio	1.79	0.44	3.15	7.1	1.8
Operating Cash Flow to Current Liabilities	-2.4	-0.46	-1.86	-8.3	-1.54
Days Sales Outstanding (Average Receivables)	-	-	-	-	4.16
Days Outstanding Inventory (Average Inventory)	-	-	2.29K	662.57	312.83
Average Days Payable Outstanding	-	-	682.9	25.17	16.46
Cash Conversion Cycle (Average Days)	-	-	-	-	300.52
Long Term Solvency
Total Debt/Equity	5.1	-1.05	0.01	0.55	0.75
Total Debt / Total Capital	4.85	-1.06	0.01	0.54	0.75
LT Debt/Equity	2.69	-0.03	-	0.32	0.25
Long-Term Debt / Total Capital	2.56	-0.03	-	0.32	0.25
Total Liabilities / Total Assets	45.27	183.23	28.34	10.77	36.8
EBIT / Interest Expense	-75.02	-	-575.38	-3.13K	-
EBITDA / Interest Expense	-74.45	-	-572.08	-3.12K	-
(EBITDA - Capex) / Interest Expense	-74.68	-	-575.23	-3.13K	-
Total Debt / EBITDA	-0.02	-0.01	-0	-0.01	-0.01
Net Debt / EBITDA	0.64	0.49	1.49	0.79	1.02
Total Debt / (EBITDA - Capex)	-0.02	-0.01	-0	-0.01	-0.01
Net Debt / (EBITDA - Capex)	0.64	0.49	1.48	0.79	1.01
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	2.35K	1.21K	433.68
Gross Profit, 1 Yr. Growth %	-	-	3.93K	1.64K	468.49
EBITDA, 1 Yr. Growth %	-	57.32	58.74	-16.22	-39.5
EBITA, 1 Yr. Growth %	50.14	57.45	58.31	-16.23	-39.31
EBIT, 1 Yr. Growth %	50.14	57.45	58.31	-16.23	-39.31
Earnings From Cont. Operations, 1 Yr. Growth %	63.21	198.44	1.39	-61.46	9.23
Net Income, 1 Yr. Growth %	63.21	198.44	0.94	-62.54	24.87
Normalized Net Income, 1 Yr. Growth %	63.21	198.44	0.68	-63.2	28.99
Diluted EPS Before Extra, 1 Yr. Growth %	14.25	122.23	-27.16	-66.21	20.95
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	301.61
Inventory, 1 Yr. Growth %	-	-	18.6	121.76	54.46
Net Property, Plant and Equip., 1 Yr. Growth %	3.07K	-41.05	-3.57	81.48	38.78
Total Assets, 1 Yr. Growth %	291.21	67.85	190.15	-44.52	-0.52
Tangible Book Value, 1 Yr. Growth %	1.01K	-355.27	-351.04	-29.39	-35.83
Common Equity, 1 Yr. Growth %	1.01K	-355.27	-351.04	-29.39	-35.83
Cash From Operations, 1 Yr. Growth %	74.23	35.8	79.79	-8.48	-35.65
Capital Expenditures, 1 Yr. Growth %	75	-	-	-36.59	76.92
Levered Free Cash Flow, 1 Yr. Growth %	-	-409.51	-284.93	-15.68	-88.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-417.72	-284.5	-15.61	-88.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	1.69K	734.74
Gross Profit, 2 Yr. CAGR %	-	-	-	2.55K	894.95
EBITDA, 2 Yr. CAGR %	-	-	58.03	15.33	-28.8
EBITA, 2 Yr. CAGR %	-	53.75	57.88	15.16	-28.7
EBIT, 2 Yr. CAGR %	-	53.75	57.88	15.16	-28.7
Earnings From Cont. Operations, 2 Yr. CAGR %	-	120.7	73.95	-37.49	-35.12
Net Income, 2 Yr. CAGR %	-	120.7	73.57	-38.5	-31.6
Normalized Net Income, 2 Yr. CAGR %	-	120.7	73.34	-39.13	-31.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-	59.34	27.23	-50.39	-36.07
Accounts Receivable, 2 Yr. CAGR %	-	-	-	456.78	-
Inventory, 2 Yr. CAGR %	-	-	-	62.18	85.08
Net Property, Plant and Equip., 2 Yr. CAGR %	-	332.05	-24.61	32.29	58.7
Total Assets, 2 Yr. CAGR %	-	156.26	120.69	26.87	-25.71
Tangible Book Value, 2 Yr. CAGR %	-	432.93	153.15	33.14	-32.69
Common Equity, 2 Yr. CAGR %	-	432.93	153.15	33.14	-32.69
Cash From Operations, 2 Yr. CAGR %	-	53.82	56.26	28.28	-23.26
Capital Expenditures, 2 Yr. CAGR %	-	-	113.44	-	5.92
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	176.69	24.86	-68.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	180.19	24.77	-68.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	1.1K
Gross Profit, 3 Yr. CAGR %	-	-	-	-	1.49K
EBITDA, 3 Yr. CAGR %	-	-	-	27.9	-6.99
EBITA, 3 Yr. CAGR %	-	-	55.25	27.81	-6.98
EBIT, 3 Yr. CAGR %	-	-	55.25	27.81	-6.98
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	70.29	5.26	-24.71
Net Income, 3 Yr. CAGR %	-	-	70.04	4.12	-22.13
Normalized Net Income, 3 Yr. CAGR %	-	-	69.89	3.41	-21.81
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	22.74	-18.22	-33.23
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	399.33
Inventory, 3 Yr. CAGR %	-	-	-	-	59.57
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	162.07	1.04	34.42
Total Assets, 3 Yr. CAGR %	-	-	167.09	39.28	16.99
Tangible Book Value, 3 Yr. CAGR %	-	-	314.66	65.4	4.39
Common Equity, 3 Yr. CAGR %	-	-	314.66	65.4	4.39
Cash From Operations, 3 Yr. CAGR %	-	-	62.03	30.74	1.92
Capital Expenditures, 3 Yr. CAGR %	-	-	99.77	42.42	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	86.19	-43.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	87.81	-43.59
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	-	-	13.73
EBIT, 5 Yr. CAGR %	-	-	-	-	13.73
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	15.76
Net Income, 5 Yr. CAGR %	-	-	-	-	18.13
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	18.41
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-5.45
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	114.43
Total Assets, 5 Yr. CAGR %	-	-	-	-	60.09
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	100.38
Common Equity, 5 Yr. CAGR %	-	-	-	-	100.38
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	20.16
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	54.99